Cart
sales@molnova.com
Home - Products - Apoptosis - Apoptosis - HFY-4A

HFY-4A

CAS No. 2094810-82-7

HFY-4A( —— )

Catalog No. M37090 CAS No. 2094810-82-7

HFY-4A is a novel HDAC inhibitor.HFY-4A has antitumour activity and has shown antiproliferative activity in breast cancer cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 73 In Stock
5MG 103 In Stock
10MG 154 In Stock
25MG 247 In Stock
50MG 361 In Stock
100MG 601 In Stock
200MG Get Quote In Stock
500MG 2115 In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    HFY-4A
  • Note
    Research use only, not for human use.
  • Brief Description
    HFY-4A is a novel HDAC inhibitor.HFY-4A has antitumour activity and has shown antiproliferative activity in breast cancer cells.
  • Description
    HFY-4A is a HDAC inhibitor. HFY-4A inhibits breast cancer cell proliferation, migration, and invasion, and induces cell apoptosis. HFY-4A induces immunogenic cell death (ICD). HFY-4A inhibits tumor growth in breast cancer xenograft mouse models.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis | HDAC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2094810-82-7
  • Formula Weight
    333.38
  • Molecular Formula
    C20H19N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(NCC1=CC=C(/C=C/C(NO)=O)C=C1)C2=NC3=C(C=C2)C=CC=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yin Y, et al. The HDAC inhibitor HFY-4A improves TUSC2 transcription to induce immunogenic cell death in breast cancer. Toxicol Appl Pharmacol. 2023 Nov 1;478:116698.?
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • TMI-1

    TMI-1 (WAY-171318), a novel orally active inhibitor of ADAM17 (TACE) and MMP, induces tumor apoptosis in a breast cancer.

  • M3541

    M3541 is a selectively potent and orally active ATM inhibitor with potential antitumor activity.M-3541 inhibits ATM kinase activity and ATM-mediated signaling by binding to ATM.

  • AGN 192870

    AGN 192870 is a potent retinoic acid receptor (RAR) antagonist.AGN 192870 can be used to study cell growth arrest, differentiation and apoptosis.

Sign In Join Free